A golden key, open a new chapter

Shandong Xinbo Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") has recently officially settled on the 5th floor of Building A in Lishan International Cell Medicine Industrial Park. The delivery ceremony will be held in the park. General Manager Liu Zhaoping, Executive Director Liu Yaling, Supervisor Liu Wenqian, Shareholder and Expert Yuan Shoujun, Expert Shen Lianzhong, along with Chairman Gao Jun, General Manager Yan Lide, Deputy General Manager Liu Guopeng, and General Manager Qiu Xueliang of Shandong Lishan Biotechnology Co., Ltd., attended the delivery ceremony. Limited company settled in Lishan International Cell Medicine Industrial Park

Good delivery, welcome to reside

At the key transfer ceremony, Gao Jun, chairman of Lishan Health Group Co., Ltd., delivered a speech to express a warm congratulations to the settlement of Shandong Xinbo. The entry of Shandong Xinbo is a new starting point for the common development of both parties. The park will join hands with Shandong Xinbo. Create a better future.

Xin Cheng Yaoqi, Li Shi Tongxing

Subsequently, the company supervisor Liu Wenqian received the facility keys on behalf of the company, and the delivery ceremony was successfully completed. After the delivery ceremony, the company's management and employee representatives jointly visited the new facilities and exchanged ideas on park layout planning and business development.
The company has settled on the 5th floor of Building A in Lishan International Cell Medicine Industrial Park. In the future, the company plans to focus on non clinical evaluation services at this facility, including safety evaluation of cell-based drugs based on organ chip technology, toxicology evaluation focused on drug sensitization research, and efficacy and pharmacokinetics research of innovative compound formulations. The company will continue to deepen cooperation with the park and promote capacity building in the non clinical evaluation field of cell therapy products.

Shandong Xinbo Pharmaceutical Technology Co., Ltd.

Shandong Xinbo has settled in the 5th floor of Building A, Building of Lishan International Cell Medicine Industrial Park this time. In the future, it will focus on the safety evaluation of cell drugs based on organ chips, toxicology evaluations featuring drug allergenic research, and to use drug allergenic research. Innovative compound preparation drug -effective pharmaceutical research is a drug research and development platform related work. Through the cooperation with Lishan International Cell Industrial Park to achieve resource sharing, complementary advantages, mutual studies, mutual benefit, and win -win results, work together to promote the development of cell therapy products, and contribute to the creation of new drugs in my country.